炎症性肠病患者结直肠肿瘤的管理
炎症性肠病(IBD)患者因慢性结肠炎症而面临结直肠肿瘤(CRN)风险增加,结直肠癌(CRC)常由结肠黏膜异型增生进展而来。多个学会指南及独立共识小组推荐了包括风险评估、药物控制炎症以及结肠镜筛查和监测等预防策略,但IBD肿瘤的预防和管理仍复杂且常令人困惑,需要重新审视不断发展的证据基础和可行的临床实践方法。
要点
- IBD患者结直肠肿瘤风险增加,CRC常由结肠黏膜异型增生进展而来。
- 多个学会指南推荐风险评估、药物控制炎症及结肠镜筛查监测等预防策略。
- IBD肿瘤预防和管理仍复杂,需重新审视证据基础和可行临床方法。
核心结论
- IBD患者结直肠肿瘤的预防和管理仍是一个复杂且常令人困惑的领域,需要仔细重新评估不断发展的证据基础和可行的临床实践方法。
研究设计与样本
- 原文为综述,未报告系统检索范围。
主要发现
- IBD包括克罗恩病和溃疡性结肠炎(UC),是胃肠道的慢性炎症性疾病。
- IBD患者发生肠道肿瘤的风险增加,尤其是结直肠肿瘤(CRN),包括结直肠异型增生和结直肠癌(CRC),这是慢性结肠炎症的结果。
- IBD患者的CRC似乎先有结肠黏膜异型增生改变。
关键数值与推荐
- 多个学会指南和独立共识小组推荐了降低CRC相关发病率和死亡率的预防策略,包括风险评估、药物控制炎症以及结肠镜筛查和监测策略并在适当间隔进行组织病理学评估。
临床怎么用
- 原文未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The inflammatory bowel diseases (IBDs), comprising Crohn’s disease and ulcerative colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract. Individuals with IBD are at an increased risk of developing intestinal neoplasia, particularly colorectal neoplasia (CRN) (including colorectal dysplasia and colorectal cancer [CRC]), as a consequence of chronic colonic inflammation.– Given that CRC in patients with IBD appears to be preceded by dysplastic changes in the colonic mucosa, prevention strategies to reduce CRC-associated morbidity and mortality have been recommended by multiple society guidelines and independent consensus groups, and include risk assessment, mitigation of inflammation with medical therapies, and screening and surveillance strategies with colonoscopy, with histopathologic assessments at appropriate intervals. Despite these efforts, prevention and management of neoplasia in IBD remains a complex and often confusing topic, requiring careful reappraisal of the evolving evidence base and practicable approaches to clinical practice.
引用
- Axelrad JE, Rubin DT. The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2024. PMID: 38432648. doi:10.1016/j.cgh.2024.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。